ID   CA5171
AC   CVCL_4U23
DR   cancercelllines; CVCL_4U23
DR   Wikidata; Q54808298
RX   PubMed=25394645;
CC   Population: Chinese; Taiwan.
CC   Doubling time: ~24 hours (PubMed=25394645).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=25394645).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Tyr27Cys (c.80A>G); ClinVar=VCV000404160; Zygosity=Unspecified (PubMed=25394645).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Unspecified (PubMed=25394645).
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
RX   PubMed=25394645; DOI=10.1177/1933719114557893; PMCID=PMC4502800;
RA   Chiang Y.-C., Cheng W.-F., Chang M.-C., Lu T.-P., Kuo K.-T., Lin H.-P.,
RA   Hsieh C.-Y., Chen C.-A.;
RT   "Establishment of a new ovarian cancer cell line CA5171.";
RL   Reprod. Sci. 22:725-734(2015).
//